1. Disease burden and management of Crigler‐Najjar syndrome: Report of a world registry
   Sem J. Aronson et al, 2022, Liver International CrossRef
2. Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy
   Jongyoon Shinn et al, 2024, ACS Nano CrossRef
3. The protective effects ofSalvia officinalisessential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high‐fat diet
   Fatma Koubaa‐Ghorbel et al, 2020, Journal of Food Biochemistry CrossRef
4. Therapeutic application and construction of bilirubin incorporated nanoparticles
   Qing Yao et al, 2020, Journal of Controlled Release CrossRef
5. The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders
   Libor Vítek, 2021, Antioxidants & Redox Signaling CrossRef
6. Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
   Yuan-dong Sun et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. Biliverdin reductase and bilirubin in hepatic disease
   Lauren Weaver et al, 2018, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef